betathine
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2000 (NCT00006466)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- alethine
- alethine
- alethine
- alethine hydrobromide
- alethine hydrochloride
- beta-alanyl cysteamine disulfide
- beta-alanyl cysteamine disulfide
- beta-alanyl-cysteamine disulfide
- beta-alanylcysteamine disulfide
- beta alethine
- beta alethine
- beta alethine
- beta-alethine
- beta-alethine
- beta-alethine
- betathine
- betathine
- betathine
- n,n'-(dithiodiethylene)bis(3-aminopropionamide)
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00041379 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2002 | LifeTime Pharmaceuticals |
| NCT00006466 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2000 | LifeTime Pharmaceuticals |
| NCT00007839 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2000 | LifeTime Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| LifeTime Pharmaceuticals | For profit | 3 | 3 | 1 | 2000 |
1 organizations
Page 1 / 1